CYMEVENE Side Effects

6762428-4 | Deafness
on Jun 04, 2010 Male patient from UNITED KINGDOM , 44 years of age, was treated with Cymevene (View Usage). Patient experienced the following unwanted or unexpected effects: deafness. Cymevene dosage: .

6376918-X | Anaemia, Bronchopulmonary Aspergillosis, Cytomegalovirus Infection, Graft Loss, Parvovirus Infection, Septic Shock
Patient was taking Cymevene (View Usage). Patient had the following side effects: anaemia, bronchopulmonary aspergillosis, cytomegalovirus infection (What is cytomegalovirus infection?), graft loss, parvovirus infection, septic shock on Sep 18, 2009 from POLAND Additional patient health information: Male patient , 54 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?), aplasia pure red cell, immunosuppression, graft versus host disease and. Cymevene dosage: . During the same period patient was treated with MABTHERA (Received A Total Of Three Doses; Total Dose: 900 Mg) (View Mabthera Review and Mabthera Label ), NEORECORMON (Between Days 151 And 179) (View Neorecormon Review and Neorecormon Label ), OVASTAT (Dose: 25 G/m2; Conditioning) (View Ovastat Review and Ovastat Label ), ENDOXAN (Conditioning) (View Endoxan Review and Endoxan Label ), CYCLOSPORINE (Discontinued On Day+90) (View Cyclosporine Review and Cyclosporine Label ), MYLERAN (Non Myeloablative Conditioning) (View Myleran Review and Myleran Label ), FLUDARA (View Fludara Review and Fludara Label ). Patient was hospitalized.

6295847-3 | Pericarditis
Adverse event was reported on Jul 30, 2009 by a Male patient taking Cymevene (View Usage) (Dosage: ) was diagnosed with cytomegalovirus gastrointestinal infection and. Location: SWEDEN , 50 years of age, After Cymevene was administered, patient had the following side effects: pericarditis. During the same period patient was treated with VALCYTE (View Valcyte Review and Valcyte Label ), URSO FALK (View Urso Falk Review and Urso Falk Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), BACTRIM (View Bactrim Review and Bactrim Label ), MYCOSTATIN ORAL SUSPENSION (View Mycostatin Oral Suspension Review and Mycostatin Oral Suspension Label ), EMGESAN (View Emgesan Review and Emgesan Label ). Patient was hospitalized.

6212657-3 | Pericarditis
on May 28, 2009 Male patient from SWEDEN , 50 years of age, was diagnosed with cytomegalovirus gastrointestinal infection and was treated with Cymevene (View Usage). Patient experienced the following unwanted or unexpected effects: pericarditis. Cymevene dosage: . During the same period patient was treated with VALCYTE (View Valcyte Review and Valcyte Label ), URSO FALK (View Urso Falk Review and Urso Falk Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), BACTRIM (View Bactrim Review and Bactrim Label ), MYCOSTATIN ORAL SUSPENSION (View Mycostatin Oral Suspension Review and Mycostatin Oral Suspension Label ), EMGESAN (View Emgesan Review and Emgesan Label ). Patient was hospitalized.


6209453-X | Pericarditis
on May 25, 2009 Male patient from SWEDEN , 50 years of age, was diagnosed with cytomegalovirus gastrointestinal infection and was treated with Cymevene (View Usage). Patient had the following side effects: pericarditis. Cymevene dosage: . During the same period patient was treated with VALCYTE (View Valcyte Review and Valcyte Label ), URSO FALK (View Urso Falk Review and Urso Falk Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), BACTRIM (View Bactrim Review and Bactrim Label ), MYCOSTATIN ORAL SUSPENSION (View Mycostatin Oral Suspension Review and Mycostatin Oral Suspension Label ), EMGESAN (View Emgesan Review and Emgesan Label ).

6017660-4 | Angioedema, Oropharyngeal Pain, Vith Nerve Paralysis
Patient was taking Cymevene (View Usage). After Cymevene was administered, patient had the following side effects: angioedema, oropharyngeal pain, vith nerve paralysis on Dec 15, 2008 from NETHERLANDS Additional patient health information: Female patient , weighting 116.8 lb, . Cymevene dosage: Dosage Form Reported As Infusion..

5914780-7 | Nasal Necrosis
Adverse event was reported on Oct 03, 2008 by a Female patient taking Cymevene (View Usage) (Dosage: ) . Location: SWITZERLAND , 60 years of age, Patient experienced the following unwanted or unexpected effects: nasal necrosis. During the same period patient was treated with MABCAMPATH (View Mabcampath Review and Mabcampath Label ).

5684741-4 | Bone Marrow Failure, Encephalitis, Neutropenia, Thrombocytopenia
on Oct 18, 1989 Female patient from BELGIUM , weighting 14.55 lb, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and was treated with Cymevene (View Usage). Patient had the following side effects: bone marrow failure, encephalitis (What is encephalitis?), neutropenia, thrombocytopenia. Cymevene dosage: . During the same period patient was treated with ORTHOCLONE OKT3 (View Orthoclone Okt3 Review and Orthoclone Okt3 Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ), ATGAM (View Atgam Review and Atgam Label ), IMIPENEM (View Imipenem Review and Imipenem Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ). Patient was hospitalized and became disabled.

5676117-0 | Angiopathy, Atrial Fibrillation, Cardiac Disorder, Graft Dysfunction, Ill-defined Disorder, Transplant Rejection, Ventricular Fibrillation
on Mar 14, 2008 Male patient from POLAND , 28 years of age, weighting 211.6 lb, was diagnosed with prophylaxis against transplant rejection and was treated with Cymevene (View Usage). After Cymevene was administered, patient had the following side effects: angiopathy, atrial fibrillation (What is atrial fibrillation?), cardiac disorder, graft dysfunction, ill-defined disorder, transplant rejection, ventricular fibrillation. Cymevene dosage: Duration 10-14 Days. During the same period patient was treated with VALCYTE (Other Indication Prevention After Cardiac Graft. Dosage Regimen 2x450 Mg) (View Valcyte Review and Valcyte Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), PROGRAFT (View Prograft Review and Prograft Label ), ENCORTON (View Encorton Review and Encorton Label ). Patient was hospitalized.

5661512-6 | Cardiac Disorder, Transplant Rejection, Ventricular Fibrillation
Patient was taking Cymevene (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac disorder, transplant rejection, ventricular fibrillation on Mar 03, 2008 from POLAND Additional patient health information: Male patient , 28 years of age, weighting 211.6 lb, . Cymevene dosage: Duration 10-14 Days. During the same period patient was treated with VALCYTE (Other Indication Prevention After Cardiac Graft. Dosage Regimen 2x450 Mg) (View Valcyte Review and Valcyte Label ). Patient was hospitalized.

5647238-3 | Cardiac Disorder, Complications Of Transplanted Heart, Cytomegalovirus Infection, Ventricular Fibrillation
Adverse event was reported on Feb 21, 2008 by a Male patient taking Cymevene (View Usage) (Dosage: Duration 10-14 Days) . Location: POLAND , 28 years of age, weighting 211.6 lb, Patient had the following side effects: cardiac disorder, complications of transplanted heart, cytomegalovirus infection (What is cytomegalovirus infection?), ventricular fibrillation. During the same period patient was treated with VALCYTE (Other Indication Prevention After Cardiac Graft. Dosage Regimen 2x450 Mg) (View Valcyte Review and Valcyte Label ). Patient was hospitalized.

5581516-1 | Azoospermia, Prostatovesiculitis
on Dec 27, 2007 Male patient from GERMANY , 37 years of age, weighting 194.0 lb, was diagnosed with immunosuppression and was treated with Cymevene (View Usage). After Cymevene was administered, patient had the following side effects: azoospermia, prostatovesiculitis. Cymevene dosage: . During the same period patient was treated with VALCYTE (View Valcyte Review and Valcyte Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), RAPAMUNE (View Rapamune Review and Rapamune Label ), DECORTIN (View Decortin Review and Decortin Label ).

5565395-4 | Deafness
on Jun 23, 2005 Female patient from UNITED KINGDOM , 72 years of age, was treated with Cymevene (View Usage). Patient experienced the following unwanted or unexpected effects: deafness. Cymevene dosage: . During the same period patient was treated with SEPTRIN (View Septrin Review and Septrin Label ).

5565280-8 | Cytomegalovirus Colitis, International Normalised Ratio Increased
Patient was taking Cymevene (View Usage). Patient had the following side effects: cytomegalovirus colitis, international normalised ratio increased on Feb 11, 2002 from UNITED KINGDOM Additional patient health information: Female patient , 72 years of age, weighting 134.5 lb, . Cymevene dosage: . During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

5425185-X | Aspergillosis, Escherichia Infection, Gastrointestinal Haemorrhage, Renal Failure
Adverse event was reported on Aug 13, 2007 by a Male patient taking Cymevene (View Usage) (Dosage: ) . Location: SWITZERLAND , 49 years of age, After Cymevene was administered, patient had the following side effects: aspergillosis, escherichia infection, gastrointestinal haemorrhage, renal failure. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), RITUXAN (View Rituxan Review and Rituxan Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), PRECORTALON (View Precortalon Review and Precortalon Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ). Patient was hospitalized.

5294918-8 | Abdominal Distension, Anaphylactic Reaction, Anxiety, Blood Bilirubin Increased, Cholestasis, Confusional State, Depression, Dyspnoea, Fatigue
on Jan 29, 2006 Female patient from SWEDEN , 37 years of age, was diagnosed with fungal infection (What is fungal infection?), cytomegalovirus gastrointestinal infection and was treated with Cymevene (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, anaphylactic reaction, anxiety (What is anxiety?), blood bilirubin increased, cholestasis, confusional state, depression (What is depression?), dyspnoea, fatigue. Cymevene dosage: Reported As X 2. Home Pump. During the same period patient was treated with MABTHERA (Dosage Regimen Reported As ^750 Mg X 2^ - 1 Dose Per Week .) (View Mabthera Review and Mabthera Label ), VFEND (Film Coated Tablet) (View Vfend Review and Vfend Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), FORTUM (View Fortum Review and Fortum Label ), SOLU CORTEF (View Solu-cortef Review and Solu-cortef Label ), TAVEGYL (View Tavegyl Review and Tavegyl Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

5288461-X | Abdominal Distension, Anaphylactic Reaction, Anxiety, Blood Bilirubin Increased, Cholestasis, Confusional State, Depression, Dyspnoea, Fatigue
on Jan 29, 2007 Female patient from SWEDEN , 37 years of age, was treated with Cymevene (View Usage). Patient had the following side effects: abdominal distension, anaphylactic reaction, anxiety (What is anxiety?), blood bilirubin increased, cholestasis, confusional state, depression (What is depression?), dyspnoea, fatigue. Cymevene dosage: Reported As 425 Mg X 2. Home Pump. During the same period patient was treated with MABTHERA (1 Dose Per Week.) (View Mabthera Review and Mabthera Label ), VFEND (View Vfend Review and Vfend Label ), DOXYFERM (View Doxyferm Review and Doxyferm Label ), FORTUM (View Fortum Review and Fortum Label ), FURIX (View Furix Review and Furix Label ), LOSEC (View Losec Review and Losec Label ), MERONEM (View Meronem Review and Meronem Label ).

5281847-9 | Hypotension, Multi-organ Failure, Sepsis
Patient was taking Cymevene (View Usage). After Cymevene was administered, patient had the following side effects: hypotension, multi-organ failure, sepsis (What is sepsis?) on Mar 01, 2007 from SWEDEN Additional patient health information: Male patient , 67 years of age, . Cymevene dosage: Form Reported As Powder For Solution For Infusion.. During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ), PROGRAF (View Prograf Review and Prograf Label ), FRAGMIN (View Fragmin Review and Fragmin Label ), MERONEM (View Meronem Review and Meronem Label ). Patient was hospitalized.

5278908-7 | Cholestasis, Circulatory Collapse, Encephalitis Viral, Peritonitis
Adverse event was reported on Mar 21, 2007 by a Female patient taking Cymevene (View Usage) (Dosage: Form Reported As Powder For Solution For Infusion. Dosage Regimen Uknown.) was diagnosed with cytomegalovirus gastrointestinal infection, immunosuppression and. Location: SWEDEN , 64 years of age, Patient experienced the following unwanted or unexpected effects: cholestasis, circulatory collapse, encephalitis viral, peritonitis. During the same period patient was treated with URSO FALK (View Urso Falk Review and Urso Falk Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), FRAGMIN (View Fragmin Review and Fragmin Label ), MIACALCIN (View Miacalcin Review and Miacalcin Label ), ANDAPSIN (View Andapsin Review and Andapsin Label ). Patient was hospitalized.

5275977-5 | Anaemia, Anuria, Cardiovascular Insufficiency, Confusional State, Dehydration, Haematemesis, Hepatic Failure, Hypotonia, Multi-organ Failure
on Mar 20, 2007 Male patient from SWEDEN , 59 years of age, was treated with Cymevene (View Usage). Patient had the following side effects: anaemia, anuria, cardiovascular insufficiency, confusional state, dehydration, haematemesis, hepatic failure, hypotonia, multi-organ failure. Cymevene dosage: Dose Frequency Reported As X2. During the same period patient was treated with ABBODOP (View Abbodop Review and Abbodop Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), DALTEPARIN SODIUM (View Dalteparin Sodium Review and Dalteparin Sodium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), FUNGILIN (View Fungilin Review and Fungilin Label ), FLAGYL (View Flagyl Review and Flagyl Label ), MEROPENEMUM (View Meropenemum Review and Meropenemum Label ). Patient was hospitalized.

5273850-X | Confusional State, Hepatic Failure, Renal Failure
on Nov 17, 2005 Male patient from SWEDEN , 60 years of age, was treated with Cymevene (View Usage). After Cymevene was administered, patient had the following side effects: confusional state, hepatic failure, renal failure. Cymevene dosage: . During the same period patient was treated with SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), CIPROFLOXACIN HYDROCHLORIDE (View Ciprofloxacin Hydrochloride Review and Ciprofloxacin Hydrochloride Label ), FLAGYL (View Flagyl Review and Flagyl Label ), FUNGILIN (View Fungilin Review and Fungilin Label ), MYCOSTATIN (View Mycostatin Review and Mycostatin Label ), WARAN (View Waran Review and Waran Label ).

5269734-3 | Hyperbilirubinaemia, Renal Failure
Patient was taking Cymevene (View Usage). Patient experienced the following unwanted or unexpected effects: hyperbilirubinaemia, renal failure on Mar 08, 2007 from SWEDEN Additional patient health information: Female patient , 45 years of age, was diagnosed with cytomegalovirus gastrointestinal infection and. Cymevene dosage: Reported Form: Powder For Solution For Infusion. Reduced Dose Due To Renal Failure.. During the same period patient was treated with TAZOCIN (Reported Form: Powder For Solution For Injection/infusion.) (View Tazocin Review and Tazocin Label ), AMBISOME (Reported Form: Powder For Solution For Infusion.) (View Ambisome Review and Ambisome Label ), PRECORTALON (View Precortalon Review and Precortalon Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ). Patient was hospitalized.

5269732-X | Cholestasis, Circulatory Collapse, Encephalitis Viral, Peritonitis
Adverse event was reported on Mar 08, 2007 by a Female patient taking Cymevene (View Usage) (Dosage: Form Reported As Powder For Solution For Infusion. Dosage Regimen Uknown.) was diagnosed with cytomegalovirus gastrointestinal infection, immunosuppression and. Location: SWEDEN , 64 years of age, Patient had the following side effects: cholestasis, circulatory collapse, encephalitis viral, peritonitis. During the same period patient was treated with URSO FALK (View Urso Falk Review and Urso Falk Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), FRAGMIN (View Fragmin Review and Fragmin Label ), MIACALCIN (View Miacalcin Review and Miacalcin Label ), ANDAPSIN (View Andapsin Review and Andapsin Label ). Patient was hospitalized.

5269065-1 | Acidosis, Cholangitis Suppurative, Hypotension, Ischaemia, Liver Transplant
on Mar 08, 2007 Male patient from SWEDEN , 61 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and was treated with Cymevene (View Usage). After Cymevene was administered, patient had the following side effects: acidosis, cholangitis suppurative, hypotension, ischaemia, liver transplant (What is liver transplant?). Cymevene dosage: Form Reported As Powder For Solution For Injection. Dosage Regimen Reported As 250 Mg.. During the same period patient was treated with AMBISOME (View Ambisome Review and Ambisome Label ), URSO FALK (View Urso Falk Review and Urso Falk Label ), PROGRAF (View Prograf Review and Prograf Label ), MERONEM (View Meronem Review and Meronem Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), FORTUM (View Fortum Review and Fortum Label ), LOSEC (View Losec Review and Losec Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

5269057-2 | Fungal Sepsis, Hypotension, Renal Failure
on Mar 08, 2007 Female patient from SWEDEN , 65 years of age, was treated with Cymevene (View Usage). Patient experienced the following unwanted or unexpected effects: fungal sepsis, hypotension, renal failure. Cymevene dosage: Form Reported As Powder For Solution For Infusion.. During the same period patient was treated with AMBISOME (View Ambisome Review and Ambisome Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), MERONEM (View Meronem Review and Meronem Label ), PRECORTALON (View Precortalon Review and Precortalon Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), URSO FALK (View Urso Falk Review and Urso Falk Label ). Patient was hospitalized.

5263603-0 | Hypotension, Multi-organ Failure, Sepsis
Patient was taking Cymevene (View Usage). Patient had the following side effects: hypotension, multi-organ failure, sepsis (What is sepsis?) on Mar 01, 2007 from SWEDEN Additional patient health information: Male patient , 67 years of age, . Cymevene dosage: Form Reported As Powder For Solution For Infusion.. During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ), PROGRAF (View Prograf Review and Prograf Label ), FRAGMIN (View Fragmin Review and Fragmin Label ), MERONEM (View Meronem Review and Meronem Label ). Patient was hospitalized.

5262448-5 | Cardiac Arrest
Adverse event was reported on Mar 01, 2007 by a Female patient taking Cymevene (View Usage) (Dosage: Form Reported As Powder For Solution For Infusion. Dosage Regimen Reported As C C. On 13 October 20+) was diagnosed with cytomegalovirus gastrointestinal infection, immunosuppression and. Location: SWEDEN , 64 years of age, After Cymevene was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?). During the same period patient was treated with URSO FALK (View Urso Falk Review and Urso Falk Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), FRAGMIN (View Fragmin Review and Fragmin Label ), MIACALCIN (View Miacalcin Review and Miacalcin Label ), ANDAPSIN (View Andapsin Review and Andapsin Label ), COMBIVENT (Reported As Combivent Nebuliser Solution (boehringer Ingelheim International Gmbh).) (View Combivent Review and Combivent Label ). Patient was hospitalized.

5258959-9 | Acidosis, Cholangitis Suppurative, Hypotension, Ischaemia, Liver Transplant, Surgical Procedure Repeated
on Feb 22, 2007 Male patient from SWEDEN , 61 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and was treated with Cymevene (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, cholangitis suppurative, hypotension, ischaemia, liver transplant (What is liver transplant?), surgical procedure repeated. Cymevene dosage: Form Reported As Powder For Solution For Injection. Dosage Regimen Reported As 250 Mg.. During the same period patient was treated with URSO FALK (View Urso Falk Review and Urso Falk Label ), PROGRAF (View Prograf Review and Prograf Label ), MERONEM (View Meronem Review and Meronem Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), FORTUM (View Fortum Review and Fortum Label ), LOSEC (View Losec Review and Losec Label ), AMBISOME (View Ambisome Review and Ambisome Label ), VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ). Patient was hospitalized.

5258640-6 | Fungal Sepsis, Hypotension, Renal Failure
on Feb 22, 2007 Female patient from SWEDEN , 64 years of age, was treated with Cymevene (View Usage). Patient had the following side effects: fungal sepsis, hypotension, renal failure. Cymevene dosage: Form Reported As Powder For Solution For Infusion.. During the same period patient was treated with SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), MERONEM (View Meronem Review and Meronem Label ), PRECORTALON (View Precortalon Review and Precortalon Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), AMBISOME (View Ambisome Review and Ambisome Label ), URSO FALK (View Urso Falk Review and Urso Falk Label ). Patient was hospitalized.

5256895-5 | Abdominal Distension, Anxiety, Blood Bilirubin Increased, C-reactive Protein Increased, Cytomegalovirus Test, Dyspnoea, Epstein-barr Virus Infection, Gastrointestinal Haemorrhage
Patient was taking Cymevene (View Usage). After Cymevene was administered, patient had the following side effects: abdominal distension, anxiety (What is anxiety?), blood bilirubin increased, c-reactive protein increased, cytomegalovirus test, dyspnoea, epstein-barr virus infection, gastrointestinal haemorrhage on Jan 29, 2007 from SWEDEN Additional patient health information: Male patient , 35 years of age, . Cymevene dosage: Four Doses Each 285 Mg Were Given At Least.. During the same period patient was treated with ABBOTICIN (View Abboticin Review and Abboticin Label ), ACETYLCYSTEINE (During Ganciclovir Intoxication.) (View Acetylcysteine Review and Acetylcysteine Label ), ALBUMIN (HUMAN) (During Ganciclovir Intoxication.) (View Albumin (human) Review and Albumin (human) Label ), ANDAPSIN (View Andapsin Review and Andapsin Label ), BACTRIM (During Ganciclovir Intoxication.) (View Bactrim Review and Bactrim Label ), CLAFORAN (View Claforan Review and Claforan Label ), DICLOCIL (During Ganciclovir Intoxication.) (View Diclocil Review and Diclocil Label ), DIFLUCAN (During Ganciclovir Intoxication.) (View Diflucan Review and Diflucan Label ). Patient was hospitalized.

5256388-5 | Cholangitis Suppurative, Hepatic Function Abnormal, Hypotension, Ischaemia
Adverse event was reported on Feb 22, 2007 by a Male patient taking Cymevene (View Usage) (Dosage: Form Reported As Powder For Solution For Injection. Dosage Regimen Reported As 250 Mg.) was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and. Location: SWEDEN , 61 years of age, Patient experienced the following unwanted or unexpected effects: cholangitis suppurative, hepatic function abnormal, hypotension, ischaemia. During the same period patient was treated with URSO FALK (View Urso Falk Review and Urso Falk Label ), PROGRAF (View Prograf Review and Prograf Label ), MERONEM (View Meronem Review and Meronem Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), FORTUM (View Fortum Review and Fortum Label ), LOSEC (View Losec Review and Losec Label ), AMBISOME (View Ambisome Review and Ambisome Label ), VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ). Patient was hospitalized.

5256387-3 | Aspergillosis, Dialysis, Escherichia Infection, Gastrointestinal Haemorrhage, Multi-organ Failure, Renal Failure
on Feb 22, 2007 Male patient from SWITZERLAND , 49 years of age, was treated with Cymevene (View Usage). Patient had the following side effects: aspergillosis, dialysis (What is dialysis?), escherichia infection, gastrointestinal haemorrhage, multi-organ failure, renal failure. Cymevene dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), MABTHERA (View Mabthera Review and Mabthera Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), PRECORTALON (View Precortalon Review and Precortalon Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ). Patient was hospitalized.

5256386-1 | Hyperbilirubinaemia, Multi-organ Failure, Renal Failure
on Feb 22, 2007 Male patient from SWEDEN , 40 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and was treated with Cymevene (View Usage). After Cymevene was administered, patient had the following side effects: hyperbilirubinaemia, multi-organ failure, renal failure. Cymevene dosage: Reported Form: Powder For Solution For Infusion. Dosage Regimen Reported As 400 Mg X 2.. During the same period patient was treated with PRECORTALON (View Precortalon Review and Precortalon Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), AMBISOME (View Ambisome Review and Ambisome Label ). Patient was hospitalized.

5256379-4 | Hyperbilirubinaemia, Renal Failure
Patient was taking Cymevene (View Usage). Patient experienced the following unwanted or unexpected effects: hyperbilirubinaemia, renal failure on Feb 22, 2007 from SWEDEN Additional patient health information: Female patient , 45 years of age, was diagnosed with cytomegalovirus gastrointestinal infection and. Cymevene dosage: Reported Form: Powder For Solution For Infusion. Reduced Dose Due To Renal Failure.. During the same period patient was treated with TAZOCIN (Reported Form: Powder For Solution For Injection/infusion.) (View Tazocin Review and Tazocin Label ), AMBISOME (Reported Form: Powder For Solution For Infusion.) (View Ambisome Review and Ambisome Label ), PRECORTALON (View Precortalon Review and Precortalon Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ). Patient was hospitalized.

5256378-2 | Aspergillosis, Escherichia Infection, Gastrointestinal Haemorrhage, Renal Failure
Adverse event was reported on Feb 22, 2007 by a Male patient taking Cymevene (View Usage) (Dosage: Form Reported As Powder For Solution For Infusion. Dosage Regimen Reported As 175 Mg X 1. Dose Was +) was diagnosed with cytomegalovirus gastrointestinal infection and. Location: SWEDEN , 49 years of age, Patient had the following side effects: aspergillosis, escherichia infection, gastrointestinal haemorrhage, renal failure. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), MABTHERA (View Mabthera Review and Mabthera Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), PRECORTALON (View Precortalon Review and Precortalon Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ). Patient was hospitalized.

5256377-0 | Hyperbilirubinaemia, Thrombocytopenia
on Feb 22, 2007 Female patient from SWEDEN , 57 years of age, was diagnosed with cytomegalovirus gastrointestinal infection and was treated with Cymevene (View Usage). After Cymevene was administered, patient had the following side effects: hyperbilirubinaemia, thrombocytopenia. Cymevene dosage: Reported Formulation: Powder For Solution For Infusion.. During the same period patient was treated with VFEND (View Vfend Review and Vfend Label ), PRECORTALON (View Precortalon Review and Precortalon Label ), FLAGYL (View Flagyl Review and Flagyl Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), TAZOCIN (View Tazocin Review and Tazocin Label ). Patient was hospitalized.

5255570-0 | Fungal Sepsis, Hypotension, Renal Failure
on Feb 22, 2007 Female patient from SWEDEN , 64 years of age, was treated with Cymevene (View Usage). Patient experienced the following unwanted or unexpected effects: fungal sepsis, hypotension, renal failure. Cymevene dosage: Form Reported As Powder For Solution For Infusion.. During the same period patient was treated with SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), MERONEM (View Meronem Review and Meronem Label ), PRECORTALON (View Precortalon Review and Precortalon Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), AMBISOME (View Ambisome Review and Ambisome Label ), URSO FALK (View Urso Falk Review and Urso Falk Label ). Patient was hospitalized.

5255384-1 | Hyperbilirubinaemia, Thrombocytopenia
Patient was taking Cymevene (View Usage). Patient had the following side effects: hyperbilirubinaemia, thrombocytopenia on Feb 22, 2007 from SWEDEN Additional patient health information: Male patient , 37 years of age, . Cymevene dosage: Form Reported As Powder Solution For Infusion. Dosage Regimen Reported As 1 Dfn.. During the same period patient was treated with MERONEM (View Meronem Review and Meronem Label ), PRECORTALON (View Precortalon Review and Precortalon Label ), BACTRIM (View Bactrim Review and Bactrim Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), AMBISOME (View Ambisome Review and Ambisome Label ). Patient was hospitalized.

5255290-2 | Hyperbilirubinaemia
Adverse event was reported on Feb 22, 2007 by a Male patient taking Cymevene (View Usage) (Dosage: Reported Form: Powder For Solution For Infusion. Dosage Regimen Was Reported As 2 Times 175 Mg.) . Location: SWEDEN , 28 years of age, After Cymevene was administered, patient had the following side effects: hyperbilirubinaemia. During the same period patient was treated with CELLCEPT (Reported Form: Powder For Concentrate For Solution For Infusion. Dosage Regimen Reported As 2 Times+) (View Cellcept Review and Cellcept Label ), MERONEM (View Meronem Review and Meronem Label ), AMBISOME (View Ambisome Review and Ambisome Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), PRECORTALON (View Precortalon Review and Precortalon Label ), BACTRIM (View Bactrim Review and Bactrim Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ). Patient was hospitalized.

5247667-6 | Abdominal Distension, Anxiety, Blood Bilirubin Increased, C-reactive Protein Increased, Cytomegalovirus Test, Dyspnoea, Epstein-barr Virus Infection, Gastrointestinal Haemorrhage, Hepatic Failure
on Jan 29, 2007 Male patient from SWEDEN , 35 years of age, was diagnosed with cytomegalovirus gastrointestinal infection and was treated with Cymevene (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, anxiety (What is anxiety?), blood bilirubin increased, c-reactive protein increased, cytomegalovirus test, dyspnoea, epstein-barr virus infection, gastrointestinal haemorrhage, hepatic failure. Cymevene dosage: . During the same period patient was treated with KONAKION (View Konakion Review and Konakion Label ), BACTRIM (View Bactrim Review and Bactrim Label ), URSO FALK (View Urso Falk Review and Urso Falk Label ), SOLU MEDROL (Powder And Solvent For Solution For Injection) (View Solu-medrol Review and Solu-medrol Label ), CALCIUM SANDOZ (View Calcium-sandoz Review and Calcium-sandoz Label ), PRECORTALON (Trade Name = Precortalon Aquosum) (View Precortalon Review and Precortalon Label ). Patient was hospitalized.

5246629-2 | Renal Failure
on Feb 15, 2007 Male patient from SWITZERLAND , 49 years of age, was treated with Cymevene (View Usage). Patient had the following side effects: renal failure. Cymevene dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), MABTHERA (View Mabthera Review and Mabthera Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), PRECORTALON (View Precortalon Review and Precortalon Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), AMBISOME (View Ambisome Review and Ambisome Label ). Patient was hospitalized.

5245218-3 | Hepatorenal Failure, Hyperbilirubinaemia
Patient was taking Cymevene (View Usage). After Cymevene was administered, patient had the following side effects: hepatorenal failure, hyperbilirubinaemia on Feb 15, 2007 from SWEDEN Additional patient health information: Female patient , 45 years of age, was diagnosed with cytomegalovirus gastrointestinal infection and. Cymevene dosage: Reported Form: Powder For Solution For Infusion. Reduced Dose Due To Renal Failure.. During the same period patient was treated with TAZOCIN (Reported Form: Powder For Solution For Injection/infusion.) (View Tazocin Review and Tazocin Label ), PRECORTALON (View Precortalon Review and Precortalon Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), AMBISOME (Reported Form: Powder For Solution For Infusion.) (View Ambisome Review and Ambisome Label ). Patient was hospitalized.

5244150-9 | Hyperbilirubinaemia, Thrombocytopenia
Adverse event was reported on Feb 15, 2007 by a Female patient taking Cymevene (View Usage) (Dosage: Reported Formulation: Powder For Solution For Infusion.) was diagnosed with cytomegalovirus gastrointestinal infection and. Location: SWEDEN , 57 years of age, Patient experienced the following unwanted or unexpected effects: hyperbilirubinaemia, thrombocytopenia. During the same period patient was treated with VFEND (View Vfend Review and Vfend Label ), PRECORTALON (View Precortalon Review and Precortalon Label ), FLAGYL (View Flagyl Review and Flagyl Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), TAZOCIN (View Tazocin Review and Tazocin Label ). Patient was hospitalized.

5241803-3 | Abdominal Distension, Abdominal Pain, Arteriosclerosis Coronary Artery, Biliary Tract Disorder, Blood Bilirubin Increased, Bone Marrow Toxicity, Cholestasis, Cytolytic Hepatitis
on Jan 18, 2007 Male patient from SWEDEN , 54 years of age, was diagnosed with cytomegalovirus gastrointestinal infection and was treated with Cymevene (View Usage). Patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), arteriosclerosis coronary artery, biliary tract disorder, blood bilirubin increased, bone marrow toxicity, cholestasis, cytolytic hepatitis. Cymevene dosage: . During the same period patient was treated with CELLCEPT (Dose Reported As 2gmd Gm D.) (View Cellcept Review and Cellcept Label ), KAVEPENIN (Form Reported As Film-coated Tablet. Dose Reported As 1gmd Gm D.) (View Kavepenin Review and Kavepenin Label ), REBIF (Maintenance Dose. Form Reported As Solution For Injection. Prefilled Syringe.) (View Rebif Review and Rebif Label ), ALVEDON (He Used Two Tablets A Couple Of Hours After Interferon Beta-1a Injection, And A Few Tablets The Oth+) (View Alvedon Review and Alvedon Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), AMBISOME (View Ambisome Review and Ambisome Label ), FK463 (View Fk463 Review and Fk463 Label ).

5241778-7 | Renal Failure
on Feb 15, 2007 Male patient from SWEDEN , 49 years of age, was diagnosed with cytomegalovirus gastrointestinal infection and was treated with Cymevene (View Usage). After Cymevene was administered, patient had the following side effects: renal failure. Cymevene dosage: Form Reported As Powder For Solution For Infusion.. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), MABTHERA (View Mabthera Review and Mabthera Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), PRECORTALON (View Precortalon Review and Precortalon Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), AMBISOME (View Ambisome Review and Ambisome Label ). Patient was hospitalized.

5240184-9 | Abdominal Distension, Anxiety, Blood Bilirubin Increased, C-reactive Protein Increased, Cytomegalovirus Test, Dyspnoea, Epstein-barr Virus Infection, Gastrointestinal Haemorrhage
Patient was taking Cymevene (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, anxiety (What is anxiety?), blood bilirubin increased, c-reactive protein increased, cytomegalovirus test, dyspnoea, epstein-barr virus infection, gastrointestinal haemorrhage on Jan 29, 2007 from SWEDEN Additional patient health information: Male patient , 35 years of age, . Cymevene dosage: Four Doses Each 285 Mg Were Given At Least.. During the same period patient was treated with ABBOTICIN (View Abboticin Review and Abboticin Label ), ACETYLCYSTEINE (During Ganciclovir Intoxication.) (View Acetylcysteine Review and Acetylcysteine Label ), ALBUMIN (HUMAN) (During Ganciclovir Intoxication.) (View Albumin (human) Review and Albumin (human) Label ), ANDAPSIN (View Andapsin Review and Andapsin Label ), BACTRIM (During Ganciclovir Intoxication.) (View Bactrim Review and Bactrim Label ), CLAFORAN (View Claforan Review and Claforan Label ), DICLOCIL (During Ganciclovir Intoxication.) (View Diclocil Review and Diclocil Label ), DIFLUCAN (During Ganciclovir Intoxication.) (View Diflucan Review and Diflucan Label ). Patient was hospitalized.

5239673-2 | Abdominal Distension, Abdominal Pain, Arteriosclerosis Coronary Artery, Fatigue, Haemorrhage, Hypotension, Liver Disorder, Multi-organ Failure, Pancreatitis Haemorrhagic
Adverse event was reported on Jan 29, 2007 by a Male patient taking Cymevene (View Usage) (Dosage: ) . Location: SWEDEN , 54 years of age, Patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), arteriosclerosis coronary artery, fatigue, haemorrhage, hypotension, liver disorder, multi-organ failure, pancreatitis haemorrhagic. During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), PHENOXYMETHYL PENICILLIN (View Phenoxymethyl Penicillin Review and Phenoxymethyl Penicillin Label ), INTERFERON BETA 1A (View Interferon Beta-1a Review and Interferon Beta-1a Label ), VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), FK463 (Replaced Vancomycin And Ambizome) (View Fk463 Review and Fk463 Label ), AMPICILLIN (View Ampicillin Review and Ampicillin Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ).

5236695-2 | Abdominal Distension, Anxiety, Blood Bilirubin Increased, C-reactive Protein Increased, Cytomegalovirus Test, Dyspnoea, Epstein-barr Virus Infection, Gastrointestinal Haemorrhage, Hypotonia
on Jan 29, 2007 Male patient from SWEDEN , 35 years of age, was treated with Cymevene (View Usage). After Cymevene was administered, patient had the following side effects: abdominal distension, anxiety (What is anxiety?), blood bilirubin increased, c-reactive protein increased, cytomegalovirus test, dyspnoea, epstein-barr virus infection, gastrointestinal haemorrhage, hypotonia. Cymevene dosage: . During the same period patient was treated with ABBOTICIN (View Abboticin Review and Abboticin Label ), ACETYLCYSTEINE (During Ganciclovir Intoxication.) (View Acetylcysteine Review and Acetylcysteine Label ), ALBUMIN (HUMAN) (During Ganciclovir Intoxication.) (View Albumin (human) Review and Albumin (human) Label ), ANDAPSIN (View Andapsin Review and Andapsin Label ), BACTRIM (During Ganciclovir Intoxication.) (View Bactrim Review and Bactrim Label ), CLAFORAN (View Claforan Review and Claforan Label ), DICLOCIL (During Ganciclovir Intoxication.) (View Diclocil Review and Diclocil Label ). Patient was hospitalized.

5235689-0 | Abdominal Distension, Abdominal Pain, Arteriosclerosis Coronary Artery, Fatigue, Haemorrhage, Hypotension, Liver Disorder, Multi-organ Failure, Pancreatitis Haemorrhagic
on Jan 29, 2007 Male patient from SWEDEN , 54 years of age, was treated with Cymevene (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal pain (What is abdominal pain?), arteriosclerosis coronary artery, fatigue, haemorrhage, hypotension, liver disorder, multi-organ failure, pancreatitis haemorrhagic. Cymevene dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), PHENOXYMETHYL PENICILLIN (View Phenoxymethyl Penicillin Review and Phenoxymethyl Penicillin Label ), INTERFERON BETA 1A (View Interferon Beta-1a Review and Interferon Beta-1a Label ), VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), FK463 (Replaced Vancomycin And Ambizome) (View Fk463 Review and Fk463 Label ), AMPICILLIN (View Ampicillin Review and Ampicillin Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ).

5234402-0 | Abdominal Distension, Anaphylactic Reaction, Anxiety, Blood Bilirubin Increased, Cholestasis, Confusional State, Depression, Dyspnoea, Fatigue
Patient was taking Cymevene (View Usage). Patient had the following side effects: abdominal distension, anaphylactic reaction, anxiety (What is anxiety?), blood bilirubin increased, cholestasis, confusional state, depression (What is depression?), dyspnoea, fatigue on Jan 29, 2007 from SWEDEN Additional patient health information: Female patient , 37 years of age, . Cymevene dosage: Reported As 425 Mg X 2. Home Pump. During the same period patient was treated with MABTHERA (1 Dose Per Week.) (View Mabthera Review and Mabthera Label ), VFEND (View Vfend Review and Vfend Label ), DOXYFERM (View Doxyferm Review and Doxyferm Label ), FORTUM (View Fortum Review and Fortum Label ), FURIX (View Furix Review and Furix Label ), LOSEC (View Losec Review and Losec Label ), MERONEM (View Meronem Review and Meronem Label ).